Preparing your experience, please wait…
K
Clinical reviews
ADA Consensus Report: MASLD in People With Diabetes
American Diabetes Association, University of Florida, and others
PDF202526 pages1.5 MB
MASLD, previously known as nonalcoholic fatty liver disease (NAFLD), is a significant but frequently unrecognized issue among people with diabetes, especially those with type 2 diabetes and obesity. The condition affects a substantial portion of this population, leading to serious health risks such as metabolic dysfunction–associated steatohepatitis (MASH), cirrhosis, and liver-related mortality. Despite these risks, awareness among patients and healthcare providers remains low, necessitating a call to action for early identification and intervention. This report emphasizes the need for screening and risk stratification to improve liver health outcomes.
No account needed
Ask this resource
Answers use this document only.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
2025 ADA Diabetes Care Standards Updates
Same clinical topic · Endocrinology
PRIMER Hypothyroidism
Same clinical topic · Endocrinology
METFORMIN―MECHANISMS OF ITS GLYCEMIA-REDUCING EFFECT
Same clinical topic · Endocrinology
SYNDROME OF INAPPROPRIATE ANTIDIURESIS: FROM PATHOPHYSIOLOGY TO MANAGEMENT
Same clinical topic · Endocrinology
GLYCEMIC EMERGENCIES
Same clinical topic · Endocrinology
DIAGNOSIS AND MANAGEMENT OF CENTRAL DIABETES INSIPIDUS IN ADULTS
Same clinical topic · Endocrinology
ANTI-OBESITY DRUGS: COMPREHENSIVE REVIEW AND EMERGING THERAPIES
Same clinical topic · Endocrinology
DRUG DELIVERY SYSTEMS FOR THYROID DISEASE TREATMENT: A MINI REVIEW ON CURRENT THERAPIES AND ALTERNATIVE APPROACHES
Same clinical topic · Endocrinology
OTHER BENEFITS OF CONTROLLING CARBOHYDRATES
Same clinical topic · Endocrinology